Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Oct 27, 2022

SELL
$0.68 - $1.49 $2,516 - $5,513
-3,700 Reduced 95.63%
169 $0
Q2 2022

Aug 15, 2022

SELL
$0.68 - $1.49 $2,516 - $5,513
-3,700 Reduced 95.63%
169 $0
Q1 2022

Oct 27, 2022

BUY
$1.07 - $3.36 $3,959 - $12,432
3,700 Added 2189.35%
3,869 $6,000
Q4 2021

Feb 14, 2022

BUY
$1.33 - $4.09 $4,921 - $15,133
3,700 Added 2189.35%
3,869 $13,000
Q3 2021

Nov 15, 2021

BUY
$1.82 - $3.2 $307 - $540
169 New
169 $0

About Petros Pharmaceuticals, Inc.


  • Ticker PTPI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 20,708,000
  • Market Cap $7.04M
  • Description
  • Petros Pharmaceuticals, Inc., a pharmaceutical company, focuses on men's health therapeutics. The company engages in the commercialization and development of Stendra, an PDE-5 inhibitor prescription medication for the treatment of erectile dysfunction (ED). It also develops and commercializes H100, a patented topical formulation candidate for th...
More about PTPI
Track This Portfolio

Track Morgan Stanley Portfolio

Follow Morgan Stanley and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.